Mirati Therapeutics, Inc.

D. E. Shaw & Co., Inc.

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/14/2024

Shares

7,693

Value ($000)

452

Weight

0.0%

2020 Q3 - 2023 Q4 (13 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/14/2024	452	0.0%	7,693	12/31/2023
2023 Q3	11/14/2023	6,082	0.0%	139,613	9/30/2023
2023 Q2	8/14/2023	9,500	0.0%	262,938	6/30/2023
2023 Q1	5/15/2023	9,131	0.0%	245,586	3/31/2023
2022 Q4	2/14/2023	9,665	0.0%	213,301	12/31/2022
2022 Q3	11/14/2022	39,559	0.1%	566,430	9/30/2022
2022 Q2	8/15/2022	21,274	0.0%	316,908	6/30/2022
2021 Q4	2/14/2022	398	0.0%	2,716	12/31/2021
2021 Q3	11/15/2021	2,177	0.0%	12,308	9/30/2021
2021 Q2	8/16/2021	19,004	0.0%	117,647	6/30/2021
2021 Q1	5/17/2021	14,033	0.0%	81,922	3/31/2021
2020 Q4	2/16/2021	13,895	0.0%	63,262	12/31/2020
2020 Q3	11/16/2020	5,872	0.0%	35,365	9/30/2020